- Hovione Loures
- Lung and Nasal administration
- Allergic rhinitis
Hovione can customize Fluticasone propionate for inhalation with an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution reproducibility with a low span and amorphous content, providing highly stable API.
Hovione Fluticasone Propionate is available since 2001 and is approved in branded, generic and 505b2 applications.
This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.